| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
18,949 |
11,717 |
$599K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
11,754 |
7,286 |
$271K |
| 20553 |
|
16,123 |
8,097 |
$221K |
| 98925 |
|
16,948 |
9,683 |
$191K |
| 20610 |
|
10,161 |
5,174 |
$149K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
17,274 |
7,361 |
$115K |
| J3490 |
Unclassified drugs |
36,464 |
11,797 |
$104K |
| 22505 |
|
6,835 |
3,184 |
$97K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
5,782 |
2,813 |
$96K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
24,150 |
12,638 |
$38K |
| 99205 |
Prolong outpt/office vis |
354 |
264 |
$31K |
| 20552 |
|
1,010 |
861 |
$22K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
179 |
137 |
$16K |
| 97760 |
|
1,105 |
773 |
$12K |
| 20605 |
|
1,001 |
536 |
$11K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
15,253 |
9,379 |
$10K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
653 |
276 |
$9K |
| 80305 |
|
713 |
526 |
$5K |
| 73562 |
|
283 |
207 |
$5K |
| G0659 |
Drug test(s), definitive, utilizing drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem), excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase), performed without method or drug-specific calibration, without matrix-matched quality control material, or without use of stable isotope or other universally recognized internal standard(s) for each drug, drug metabolite or drug class per specimen; qualitative or quantitative, all sources, includes specimen validity testing, per day, any number of drug classes |
81 |
68 |
$4K |
| 72100 |
|
241 |
152 |
$4K |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
4,164 |
2,973 |
$3K |
| 97161 |
|
43 |
32 |
$2K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
48 |
43 |
$2K |
| 95913 |
|
32 |
18 |
$2K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
148 |
101 |
$1K |
| 96002 |
|
99 |
61 |
$593.76 |
| 73030 |
|
43 |
25 |
$428.23 |
| 72040 |
|
18 |
14 |
$419.21 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
304 |
181 |
$405.21 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
12,559 |
5,982 |
$334.24 |
| 73600 |
|
113 |
59 |
$264.29 |
| 73610 |
|
20 |
12 |
$244.24 |
| 97032 |
|
54 |
45 |
$214.06 |
| 97014 |
|
18 |
13 |
$177.30 |
| 94760 |
|
214 |
168 |
$168.79 |
| J7999 |
Compounded drug, not otherwise classified |
4,129 |
1,709 |
$20.30 |
| 97124 |
|
19 |
16 |
$17.58 |
| J2795 |
Injection, ropivacaine hydrochloride, 1 mg |
149 |
136 |
$6.03 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
121 |
75 |
$4.08 |
| S0020 |
Injection, bupivicaine hydrochloride, 30 ml |
16 |
12 |
$0.00 |
| 97010 |
|
13 |
12 |
$0.00 |
| L0630 |
Lumbar-sacral orthosis, sagittal control, with rigid posterior panel(s), posterior extends from sacrococcygeal junction to t-9 vertebra, produces intracavitary pressure to reduce load on the intervertebral discs, includes straps, closures, may include padding, stays, shoulder straps, pendulous abdomen design, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise |
20 |
14 |
$0.00 |